A rational connection of inflammation with peripheral arterial disease

Medical Hypotheses

Volumn 69, Issue 6, 2007, Pages 1190-1195

  Li, Jie ^a   Li, Jian Jun ^a   Li, Qian ^b   Li, Zhen ^a   Qian, Hai Yan ^a  

^a FUWAI HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CLAUDICATION; DIABETES MELLITUS; DISEASE ASSOCIATION; GENDER; HEREDITY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; LIMB ISCHEMIA; PRIORITY JOURNAL; PROGNOSIS; RESTENOSIS; RISK FACTOR; SMOKING;

ADULT; AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; HUMANS; INFLAMMATION; MIDDLE AGED; MODELS, THEORETICAL; ODDS RATIO; PERIPHERAL VASCULAR DISEASES; PROGNOSIS; RISK; STROKE; TREATMENT OUTCOME;

EID: 35448958122     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.02.043     Document Type: Article

References (24)

1. TransAtlantic Inter-Society Consensus (TASC). Management of peripheral arterial disease (PAD). Eur J Vasc Endovasc Surg 2000;19:S1-S250.
2. Tsakiris D.A., Tschopl M., Jaeger K., et al. Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis 142 (1999) 193-200
3. Kannel W.B., and McGee D.L. Update on som epidemiologic features of intermittent claudication. J Am Geriatr Soc 33 (1985) 13-18
4. Palmer-kazen U., and Wahlberg E. Arteriogenesis in peripheral arterial disease. Endothelium 10 (2003) 225-232
5. Li J.-J. Inflammation: an important mechanism for different clinical entities of coronary artery disease. Chin Med J 118 (2005) 1817-1826
6. Hanson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
7. Li J.-J., and Hu S.-S. Early, intensive and long-term statin therapy in acute coronary syndrome: focus on an anti-inflammatory mechanism. Vasc Dis Prevent 2 3 (2005) 181-186
8. Luther M., Lepantalo M., Alback A., and Matzke S. Amputation rates as a measure of vascular surgical results. Brit J Surg 83 (1996) 241-244
9. Newman A.B., Sutton-Tyrell K., Vogt M.T., and Kuller L.H. Morbidity and mortality in hypertensive adults with low ankle-arm blood pressure index. JAMA 270 (1993) 487-489
10. Gruppo di Studio dell Ischemia Cronica degli Arteri Inferior. Long-term mortality and its predicator in patients with critical leg ischemia. Eur J Vasc Endovasc Surg 1997;14:91-5.
11. Aboyans V., Criqui M.H., Denenberg J.O., et al. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 113 (2006) 2623-2629
12. Quriel K., and Zarins C.K. Doppler ankle pressure: an evaluation of three methods of expression. Arch Surg 117 (1982) 1297-1300
13. Criqui M.H., Browner D., Fronek A., et al. Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease. Am J Epidemiol 129 (1989) 1110-1119
14. Li J.-J., Li Y.-S., Zhang Y., et al. Inflammation: a possible pathogenic link to cardiac syndrome X. Med Hypotheses 66 (2006) 87-91
15. Li J.-J., and Fang C.-H. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular disease. Med Hypotheses 62 (2004) 499-506
16. Signorelli S.S., Mazzarino M.C., Pino L.D., et al. High circulating levels of cytokines (IL-6 and TNFα), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test. Vasc Med 8 (2003) 15-19
17. Beckman J.A., Preis O., Ridker P.M., et al. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). Am J Cardiol 96 (2005) 1374-1378
18. kaperonis E.A., Liapis C.D., kakisis J.D., et al. Inflammation and Chlamydia pneumoniae infection correlate with severity of peripheral arterial disease. Eur J Vasc Endovasc Surg 31 (2006) 509-515
19. Wildman R.P., Muntner P., Chen J., et al. Relation of inflammation to peripheral arterial disease in the National Health and Nutrition Examination Survey, 1999-2002. Am J Cardiol 96 (2005) 1579-1583
20. Fiotti N., Giansante C., Ponte E., et al. Atherosclerosis and inflammation. Pattern of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis 145 (1999) 51-60
21. Engstrom G., Site-Flondell D., Lindblad B., et al. Risk of treatment of peripheral disease is related to inflammation-sensitive plasma proteins: a prospective cohort study. J Vasc Surg 40 (2004) 1101-1105
22. Unlu Y., Karapolat S., Karaca Y., and Kiziltunc A. Comparison of levels of inflammatory markers and hemostatic factors in the patients with and without PAD. Thromb Res 117 (2006) 357-364
23. Mlekusch W., Exner M., Schillinger M., et al. E-selectin and restenosis after femoropopliteal angioplasty: prognostic impact of the Ser 128Arg genotype and plasma levels. Thromb Haemost 91 (2004) 171-179
24. Schillinger M., Exner M., Mlekusch W., et al. Vascular inflammation and percutaneous transluminal angioplasty: association with restenosis. Radiology 225 (2002) 21-26